InvestorsHub Logo

BioChica

11/01/19 11:59 AM

#222316 RE: sharinky #222314

We want to see a successful EPANOVA trial but with results that run around 10-15% reduction in CVD, Otherwise O3 trials for CVD reduction will get scrutinized including REDUCE-IT.



MNBioMike

11/01/19 12:03 PM

#222318 RE: sharinky #222314

Yep, I reached out to Yee to point this out.